why choose us

300×250 Ad Slot

Research Article: HOMA-beta independently predicts survival in patients with advanced cancer on treatment with immune checkpoint inhibitors

Date Published: 2024-12-11

Abstract:
Background: Although immune checkpoint inhibitors (ICIs) are effective cancer drugs, ICI-induced diabetes is a rare but a life-threatening adverse event for patients. The deleterious action of ICI on pancreatic beta-cell function is a concern. However, the influence of ICI on insulin synthesis and secretion in patients with cancer without diabetes remains unknown.

No summary available.

300×250 Ad Slot